Cancer | miRNA | Phenotype | Targets | Reference |
---|---|---|---|---|
Lung cancer | miR-132/212 | TS | CyclinD1 | [72] |
 (NSCLC) | miR-124 | TS | SOX8 | [73] |
miR-126 | TS | VEGF-PI3K-Akt-MRP1 | [74] | |
miR-181 | TS | Bcl2 | [75] | |
miR-34a | TS | TGFβR2 | [76] | |
miR-145 | TS | Oct-4 | [77] | |
miR-21 | OG | PDCD4 | [78] | |
miR-137 | PM | SLC22A18 | [79] | |
Gastro-intestinal cancers | ||||
 Gastric cancer | miR-335 | TS | RASA1 | [80] |
miR-374b-5p | OG | RECK | [81] | |
miR-490-3p | OG | SMARCD1 | [82] | |
miR-199a-3p | OG | ZHX1 | [83] | |
 Colorectal cancer | miR-185 | TS-PM | STIM1 | [84] |
miR-92a | OG-PM | PTEN | [85] | |
miR-7 | TS-PM | EGFR | [86] | |
 Hepatocellular carcinoma | miR-9 | PM |  | [87] |
miR-150-5p | TS | MMP14 | [88] | |
miR-21 | OG-PM | AP1 | [89] | |
miR-122 | TS | Hnf4α-GALNT10-EGFR | [90] | |
miR-486-5p | TS | PIK3R1 | [91] | |
 Esophageal cancer | miR-101, miR-127 | TS | MALAT1 | [92] |
miR-126 | TS | DNMT1/ADAM9-EGFR | [93] | |
miR-27a | TS | K-Ras | [94] | |
Haematological cancers | Â | Â | Â | Â |
 Lymphoma | miR-155-3p, | TS | LT-β | [95] |
 | miR-224 | TS-PM | CD59 | [96] |
miR-17-92 | OG | Sin3b, Hbp1, Suv420h1, Btg1, Bim | [97] | |
 Leukaemia | miR-486-5p | OG | AKT-FOXO1 | [98] |
 | miR-22 | OG | PTEN | [99] |
 | miR-638 | TS | CDK2 | [100] |
Reproductive cancers | ||||
 Cervical cancer | miR-126 | TS-PM | PTEN | [101] |
miR-21, Let-7a | OG/TS | STAT3 | [102] | |
miR-375 | DR | E-cadherin | [103] | |
 Prostate cancer | miR-3195, miR-374b | TS | HIF-1α, HIF-2α and VEGF | [104] |
miR-218 | TS | TPD52 | [105] | |
miR-449b | PM | Â | [106] | |
Breast cancer | miR-873 | TS-DR | ERα–CDK3 | [107] |
miR-18b, miR-103, miR-107 and miR-652 | PM | Â | [108] | |
miR-7 | TS-DR | EGFR, Src kinase | [109] | |
Glioblastoma | miR-125a-5p | TS | TAZ | [110] |
miR-155 | OG-DR | MAPK13 and MAPK14 | [111] | |
miR-449a | TS | MAZ | [112] | |
miR-148a | TS | Oct4, Sox-2 | [113] |